Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2026-01-28 @ 7:30 PM
Study NCT ID:
NCT05716295
Status:
TERMINATED
Last Update Posted:
2024-05-08
First Post:
2023-01-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid Tumors
Sponsor:
Medikine, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced or Metastatic Solid Tumors | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | MDK-703 | View |
| None | IL-7 | View |
| None | Interleukin 7 | View |
| None | Interleukin-7 | View |
| None | IL7 | View |
| None | oncology | View |
| None | immuno-oncology | View |
| None | immunotherapy | View |
| None | solid tumor | View |
| None | advanced solid tumor | View |
| None | metastatic solid tumor | View |
| None | neoplasms | View |
| None | solid malignancies | View |
| None | pancreatic cancer | View |
| None | PDAC | View |
| None | MSS-CRC | View |
| None | microsatellite stable CRC | View |
| None | microsatellite stable colorectal cancer | View |
| None | prostate cancer | View |
| None | breast cancer | View |
| None | ovarian cancer | View |
| None | immune cold | View |